Who can you meet at the Gross-to-Net Accounting Forum?

The Gross-to-Net Accounting Forum is less than a month away, taking place June 17-18 in Boston. Demand from small to mid-size pharma companies has been extremely high, indicating how timely and relevant GTN content is to your business—and bottom line.

As in most industries, small to mid-sized biopharmaceutical manufacturers have different challenges from their larger counterparts. In the Gross-to-Net space, while larger companies have a variety of people across several functions involved in the process, smaller companies make do with far fewer resources. Join the following small-mid size companies that are coming to GTN to find the solutions to their problems and yours alike:

•	Actient	•	Leo Pharma
•	AMAG	•	Neos Therapeutics
•	ARIAD	•	Purdue
•	Covidien	•	Salix
•	Exelixis	•	Shionogi Inc.
•	Forest Laboratories	•	Sunovion
•	Grifols	•	Vertex
•	Jazz Pharmaceuticals	•	Vertical / Trigen

Attend these spotlight sessions to help your bottom line: 

• Process Evaluation for Small to Mid-Sized Pharmaceutical Companies
• Benchmark Your Gross-to-Net Processes, Systems & Methodologies: Top 10 GTN Hot Topics
• Account for the Government Pricing and Contracting Impact on Gross-to-Net Calculations
• Commercial Contracts and Gross-to-Net for Managed Care

To view our full program, download our brochure.

As a reader of the Healthcare Insights Blog you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you next month!

Best,
The Pharmaceutical Accounting, Financial, & Reporting Team

Visit our Homepage
Follow us on Twitter